NBDF 2026 Conference Preview – Top Sessions for HCP

The 2026 annual meeting of the National Bleeding Disorders Foundation (NBDF) is quickly approaching. The 2026 Bleeding Disorders Conference (BDC) is set for August 13 through August 15, in Orlando, Florida. For three days, BDC 2026 features informative sessions, networking opportunities, continuing education credits, and more. 

BDC 2026 features three types of closed sessions: Chapter, consumer, and providers. Today, we are featuring a rundown of key sessions taking place in the providers track, which are exclusive for healthcare providers. View the BDC 2026 program for a complete look at all available sessions. Please note that the following times and dates are accurate as of July 9, 2026. Consult the official BDC website for the most up-to-date information.

Key Provider Sessions at BDC 2026

Thursday, August 13

• Practical Strategies for Bridging Barriers to HTC Care
  • 1:30 PM – 4:45 PM
  • Description: Bleeding disorders care and hemophilia treatment center (HTC) access are under increasing pressure—from policy shifts and payer dynamics to social and legal forces that directly affect patient engagement. In this timely session, expert panelists will examine emerging public policy changes and their implications for patient out-of-pocket costs, care continuity, and the sustainability of the integrated HTC model.

• Pre-Con | HCP: Bleeding & Depleting, Diving into VWD and IDA
  • 1:30 PM – 4:45 PM
  • Description: This session will enhance our knowledge of von Willebrand disease, focusing on the genetics, symptoms, and treatment of VWD, and the key role of nurses in patient education. We will also discuss iron deficiency anemia, the treatment options, and patient care.

• Pre-Con | HCP: Von Willebrand Disease (VWD)
  • 1:30 PM – 4:45 PM
  • Description: [The presenters] will be delving into the various types of von Willebrand disease, testing for VWD, and the important patterns and limitations to consider in diagnosis and treatment. [The session] will discuss the pathophysiology, bleeding patterns, and hematologic concerns pertaining to this population. Specific attention will be given to physical therapy, common orthopedic or MSK presentations, red flag identification, exercise modifications, and patient and family education.

Friday, August 14

• Optimizing Maternal and Neonatal Outcomes in Bleeding Disorders
  • 9:00 AM – 12:15 PM
  • Description: Pregnancies when a bleeding disorder is involved can represent a variety of urgent clinical challenges throughout the perinatal period — including bleeding risk for newborns and the need for awareness of the mother’s fluctuating factor levels and the resulting potential complications at delivery or in postpartum. This dynamic session will explore these at-risk pregnancies, delving into best practices for ensuring the safety and well-being of both mother and child. 

• An Exploration of Bleeding Disorders of Unknown Cause
  • 10:45 AM – 12:15 PM
  • Description: Bleeding Disorders of Unknown Cause (BDUC) represent a growing and often challenging area of hemostasis care, in which patients experience clinically significant bleeding despite normal standard laboratory results. This session will explore the evolution of the BDUC diagnosis, outline suggested diagnostic criteria, describe the clinical features, and review emerging theories surrounding this complex patient population.

• A Balancing Act: Evolving Care with New Therapies
  • 2:00 PM – 3:30 PM
  • Description: Treatment options for bleed prevention and management in hemophilia are ever evolving and transforming patient care. Join [the session] as [the presenters] explore novel therapies and hear real-world experiences with these new, often life-changing medications.
    

• Practical Management of Aging Patients with Hemophilia
  • 2:00 PM – 5:15 PM
  • Description: This session is designed exclusively for clinicians looking to enhance their ability to recognize age-related comorbidities, and learn complex management strategies that can be used in clinical practice. A primary feature of this important session is the introduction of a brand new series of geriatric-focused recommendations developed by NBDF’s Medical and Scientific Advisory Council (MASAC).

Saturday, August 15

• Navigating Inhibitors
  • 9:00 AM – 10:30 AM
  • Description: In this session providers and nurses will provide information about the management of inhibitors in adults and children with congenital hemophilia, new and emerging therapies, and treatments for acquired hemophilia A. We will also discuss the nurse role in monitoring, prevention, and treatment of inhibitors.

• Managing Milds: Updates on Patient Care in Mild Bleeding Disorders
  • 9:00 AM – 12:15 PM
  • Description: This session will delve into the myriad challenges and nuances associated with screening for mild bleeding disorders and managing these patients. Faculty will explore research findings on correlations and discrepancies between genotype and phenotype of hemophilia A, including implications for treatment and management. The latest clinical trial updates on novel therapies designed for use in people with von Willebrand disease will also be discussed.

• Translating What We Know Into Get Up and Go
  • 10:45 AM – 12:15 PM
  • Description: Research supports physical activity in people with bleeding disorders and has been shown to be safe and effective in reducing pain and improving strength, coordination and balance even for people with joint hemarthropathy. This session will review the literature on physical activity for PWBD, discuss biopsychosocial barriers and facilitators of physical activity for PWBD, and stimulate sharing of clinical experiences and tools. 

Don't miss out on our other hematology-related content and be sure to sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.